Teva Pharma Industries Ltd ADR (TEVA) Stock Analysis

Teva Pharma Industries Ltd ADR (TEVA) is a publicly traded company in the HEALTHCARE sector. It trades at $33.06, carries a market capitalization of $41.13B, a price-to-earnings ratio of 26.36. This page summarizes the public market data, fundamentals, and frequently asked questions for TEVA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NYSE

Key Metrics

Market Sentiment

Teva Pharma Industries Ltd ADR currently has a Bullish sentiment score of 0.26.

About Teva Pharma Industries Ltd ADR

Teva Pharmaceutical Industries Limited (Ticker: TEVA) is a global leader in the development, manufacturing, and distribution of generic and specialty pharmaceuticals, as well as biopharmaceuticals, with a strong presence in North America, Europe, and beyond. Headquartered in Petach Tikva, Israel, Teva's extensive product portfolio addresses a wide range of therapeutic areas, positioning the company as a pivotal player in the pharmaceutical industry. With a commitment to innovation and accessi...

GNG Research Analysis

GNG Research scores Teva Pharma Industries Ltd ADR (TEVA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for TEVA.

Frequently Asked Questions

Does TEVA pay dividends?

Teva Pharma Industries Ltd ADR (TEVA) does not currently pay a regular dividend.

What is TEVA's P/E ratio?

Teva Pharma Industries Ltd ADR has a price-to-earnings (P/E) ratio of 26.36.

What is TEVA's market cap?

Teva Pharma Industries Ltd ADR (TEVA) has a market capitalization of $41.13B with a current stock price of $33.06.